EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
Recruiting
Observational Study
Breast Cancer
Ductal Carcinoma In Situ
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- Thomas Jefferson University · Other
Who this trial is looking for
This trial is looking for women who are 18 years or older and have been diagnosed with breast cancer but haven't started any treatment yet. It's important that they can speak English and are in good enough health to participate. Women who have already started cancer treatment or have had another type of cancer in the last six months won’t be able to join.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a pilot trial to assess how measures of inflammation are correlated with Social Determinants of Health (SDoH) in breast cancer patients. Expected duration of subject participation is one single time point. The patients will fill out questionnaires and provide a plasma sample.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Individuals must meet all the following inclusion criteria to be eligible to participate in the study:
1. Female
2. \>18 years old at time of consent
3. Biopsy proven invasive breast cancer or ductal carcinoma in situ
4. Candidate has not yet received cancer therapy f…
Contacts